We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Wells Fargo
WFC
$264B
| $905K | 0.1% |
21,204
+12,204
| +136% | +$491K |
|
127
TSMC
TSM
$2.18T
| $867K | 0.09% |
8,592
-252
| -3% | -$23.5K |
|
128
NextEra Energy
NEE
$177B
| $865K | 0.09% |
11,663
-211
| -2% | -$16K |
|
129
ExxonMobil
XOM
$634B
| $859K | 0.09% |
8,013
+116
| +1% | +$12.7K |
|
130
Accenture
ACN
$108B
| $852K | 0.09% |
2,762
+122
| +5% | +$35.5K |
|
131
TC Energy
TRP
$65.9B
| $837K | 0.09% |
20,711
+6,282
| +44% | +$256K |
|
132
ProShares UltraPro QQQ
TQQQ
$37.9B
| $820K | 0.09% |
40,000
| – | – |
|
133
Altria Group
MO
$114B
| $810K | 0.09% |
17,890
-5
| -0% | -$226 |
|
|
ACR
134
ACRES Commercial Realty
ACR
$108M
| $806K | 0.09% |
91,214
-1,450
| -2% | -$12.6K |
|
135
Linde
LIN
$226B
| $803K | 0.09% |
2,107
-541
| -20% | -$198K |
|
136
Applied Materials
AMAT
$428B
| $800K | 0.09% |
5,534
-622
| -10% | -$77.9K |
|
|
NVO
137
Novo Nordisk
NVO
$209B
| $794K | 0.08% |
9,812
+16
| +0.2% | +$1.31K |
|
138
Motorola Solutions
MSI
$77.4B
| $794K | 0.08% |
2,706
-23
| -0.8% | -$6.59K |
|
139
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.5B
| $792K | 0.08% |
3,446
-270
| -7% | -$58.7K |
|
140
BP
BP
$107B
| $791K | 0.08% |
22,428
+16,297
| +266% | +$603K |
|
141
Albertsons Companies
ACI
$5.83B
| $785K | 0.08% |
35,986
-19
| -0.1% | -$395 |
|
142
T-Mobile US
TMUS
$190B
| $782K | 0.08% |
5,629
+1,243
| +28% | +$174K |
|
143
Norfolk Southern
NSC
$75.1B
| $776K | 0.08% |
3,420
+219
| +7% | +$46.5K |
|
144
Western Midstream Partners
WES
$19.3B
| $768K | 0.08% |
28,947
+696
| +2% | +$18.3K |
|
145
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$8.78B
| $765K | 0.08% |
20,627
-2,240
| -10% | -$82.7K |
|
146
Progressive
PGR
$125B
| $763K | 0.08% |
5,765
-2,574
| -31% | -$345K |
|
147
State Street Industrial Select Sector SPDR ETF
XLI
$33.7B
| $739K | 0.08% |
6,890
+5,885
| +586% | +$593K |
|
148
Medtronic
MDT
$112B
| $734K | 0.08% |
8,332
+1,825
| +28% | +$157K |
|
149
Regeneron Pharmaceuticals
REGN
$80.8B
| $714K | 0.08% |
993
-48
| -5% | -$37K |
|
150
Intel
INTC
$513B
| $713K | 0.08% |
21,314
+1,583
| +8% | +$49.7K |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.